Alkermes (FRA:8AK) Total Assets : €1,963 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Alkermes Total Assets?

Alkermes's Total Assets for the quarter that ended in Dec. 2024 was €1,963 Mil.

During the past 12 months, Alkermes's average Total Assets Growth Rate was -4.30% per year. During the past 3 years, the average Total Assets Growth Rate was -4.30% per year. During the past 5 years, the average Total Assets Growth Rate was 0.40% per year. During the past 10 years, the average Total Assets Growth Rate was 0.60% per year.

During the past 13 years, Alkermes's highest 3-Year average Total Assets Growth Rate was 74.70%. The lowest was -37.10%. And the median was 2.10%.

Total Assets is connected with ROA %. Alkermes's annualized ROA % for the quarter that ended in Dec. 2024 was 28.66%. Total Assets is also linked to Revenue through Asset Turnover. Alkermes's Asset Turnover for the quarter that ended in Dec. 2024 was 0.21.

Alkermes Total Assets Historical Data

The historical data trend for Alkermes's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Total Assets Chart

Alkermes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

1,602.68

1,791.67

1,854.00

1,958.92

1,963.07

Alkermes Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															1,958.92	1,953.98	2,050.16	1,941.92	1,963.07

Alkermes Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alkermes's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	1399.053	+	564.013
	=	1,963

Alkermes's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	1399.053	+	564.013
	=	1,963

Alkermes (FRA:8AK) Total Assets Explanation

Total Assets is connected with ROA %.

Alkermes's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	559.64	/	( (1941.917	+	1963.066)	/ 2 )
	=	559.64	/	1952.4915
	=	28.66 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alkermes's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	410.637	/	( (1941.917	+	1963.066)	/ 2 )
=	410.637	/	1952.4915
=	0.21

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alkermes Total Assets Related Terms

Thank you for viewing the detailed overview of Alkermes's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkermes Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (FRA:8AK) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

ALKS:USA 8AK:Germany

Address

1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6

Website

https://www.alkermes.com

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Alkermes Headlines

No Headlines